Summit Financial Group, Inc. Abb Vie Inc. Transaction History

Summit Financial Group, Inc.

$279 Million
Q1 2024

A detailed history of Summit Financial Group, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Summit Financial Group, Inc. holds 10,067 shares of ABBV stock, worth $2.02 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares

10,067

Previous 10,137 0.69%

Holding current value

$2.02 Million

Previous $1.57 Million 16.75%

% of portfolio

0.66%

Previous 0.6%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 05, 2024	SELL	$159.82 - $182.1 $11,187 - $12,747	-70 Reduced 0.69%	10,067 $1.83 Million
Q4 2023 Jan 12, 2024	SELL	$137.6 - $154.97 $4,128 - $4,649	-30 Reduced 0.3%	10,137 $1.57 Million
Q3 2023 Oct 17, 2023	SELL	$133.59 - $154.65 $116,223 - $134,545	-870 Reduced 7.88%	10,167 $1.52 Million
Q2 2023 Jul 13, 2023	SELL	$132.51 - $164.9 $5,300 - $6,596	-40 Reduced 0.36%	11,037 $1.49 Million
Q4 2022 Jan 09, 2023	BUY	$138.31 - $165.87 $23,651 - $28,363	171 Added 1.57%	11,077 $1.79 Million
Q3 2022 Oct 12, 2022	BUY	$134.21 - $153.93 $86,968 - $99,746	648 Added 6.32%	10,906 $1.46 Million
Q1 2022 Apr 08, 2022	SELL	$131.98 - $163.75 $227,797 - $282,632	-1,726 Reduced 14.4%	10,258 $1.66 Million
Q4 2021 Jan 10, 2022	BUY	$107.43 - $135.93 $174,466 - $220,750	1,624 Added 15.68%	11,984 $1.62 Million
Q3 2021 Oct 08, 2021	SELL	$106.4 - $120.78 $78,736 - $89,377	-740 Reduced 6.67%	10,360 $1.12 Million
Q2 2021 Jul 06, 2021	BUY	$105.21 - $117.21 $101,001 - $112,521	960 Added 9.47%	11,100 $1.25 Million
Q1 2021 Apr 07, 2021	BUY	$102.3 - $112.62 $23,017 - $25,339	225 Added 2.27%	10,140 $1.1 Million
Q4 2020 Jan 07, 2021	BUY	$80.49 - $108.67 $28,171 - $38,034	350 Added 3.66%	9,915 $1.06 Million
Q1 2020 Apr 03, 2020	SELL	$64.5 - $97.79 $2,580 - $3,911	-40 Reduced 0.42%	9,565 $729,000
Q3 2019 Oct 09, 2019	SELL	$62.98 - $75.72 $125,960 - $151,440	-2,000 Reduced 17.23%	9,605 $727,000
Q2 2019 Jul 03, 2019	SELL	$65.7 - $83.98 $3,285 - $4,199	-50 Reduced 0.43%	11,605 $844,000
Q1 2019 Apr 03, 2019	SELL	$77.14 - $90.79 $3,857 - $4,539	-50 Reduced 0.43%	11,655 $939,000
Q3 2018 Oct 03, 2018	SELL	$88.91 - $98.84 $444 - $494	-5 Reduced 0.04%	11,705 $1.11 Million
Q2 2018 Jul 03, 2018	SELL	$89.78 - $106.23 $17,956 - $21,246	-200 Reduced 1.68%	11,710 $1.09 Million
Q1 2018 Apr 04, 2018	BUY	$92.01 - $123.21 $184 - $246	2 Added 0.02%	11,910 $1.13 Million
Q3 2017 Oct 10, 2017	BUY	$69.85 - $89.22 $831,773 - $1.06 Million	11,908	11,908 $1.06 Million

Others Institutions Holding ABBV

# of Institutions

3,773

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.82M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $354B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Summit Financial Group, Inc. with notifications on news.

Account

Summit Financial Group, Inc. Abb Vie Inc. Transaction History